Past Events
2024
Global Availability of Critical Reagents for Biologicals Testing. Current Status, Challenges and Possible Solutions
July 2, 2024
Webinar
Global Availability of Critical Reagents for Biologicals Testing. Current Status, Challenges and Possible Solutions
July 2, 2024
Webinar
IABS – DCVMN Meeting NGS Testing to Replace In Vivo Adventitious Testing for Old & New Vaccines
June 19-20, 2024
Brussels, Belgium
2023
9th Annual Statistics Workshop
Applying Statistics and Data Science to Evolving Technical and
Regulatory Paradigm
Hybrid Meeting.h
Novembre, 7-9, 2023
Rockville, USA.
The Role of Real-World Evidence for Regulatory and Public Health Decision Making for Accelerated Vaccine Deployment
Hybrid Meeting.h
September, 19-20, 2023
Leuven, Belgium
Maintaining the Quality of Vaccines through the Use of References Standards
Hybrid Meeting.h
June, 21-23, 2023
Ottawa, Canada
4th Controlled Human Infection Model (CHIM)
Hybrid Meeting
May, 22-24, 2023
Mombasa, Kenya
Enabling the Evaluation of COVID-19 Vaccines with Correlates of Protection
A Hybrid Meeting
.
February, 16-17, 2023
Antwerp, Belgium
Globally Harmonized Specifications: Current State and Future Opportunities
A Hybrid Meeting
.
January, 10-12, 2023
Basel, Switzerland
2022
3Rs implementation in veterinary vaccine batch-release testing: Current state-of-the-art and future opportunities
November 16, 2022
Brussels, Belgium
8th Annual IABS Statistics Workshop – Advancing the Impact of CMC Statistics for a New Generation of Statisticians, Scientists, and Modelers
November 7-10, 2022
A virtual Meeting
IABS Meeting on High Pathogenicity Avian Influenza Vaccination Strategies to prevent and control HPAI : Removing unnecessary barriers for usages
October 25 – 26, 2022
Paris, France
3Rs implementation in veterinary vaccine batchrelease testing: Current state-of-the-art and future opportunities
October 20, 2022
A virtual Meeting
3Rs implementation in veterinary vaccine batchrelease testing: Current state-of-the-art and future opportunities
October 6, 2022
A virtual Meeting
IABS Gene Therapy Webinar
Standards for Gene Therapy Viral Vector
March 22, 2022
A virtual Meeting
2021
Drive Annual Forum Webinar
November 30, 2021
7th IABS Statistics Workshop
Accelerating Drug Development: How QbD, Regulatory Partnerships, and Pandemic Learning Can Further Expedite Meeting Patient Needs
November 8-11, 2021
Autogenous Vaccines Meeting
Quality of Production and Movement in a Common Market
September 14-16, 2021
Munich, Germany
Evolution of FMT
Evolution of FMT – From Early Clinical to Standardized Treatments
May 21, 2021
A Virtual Meeting
Current Efforts in African Swine Fever Vaccines Webinar
May 6, 2021
A Virtual Seminar and Discussion
Human Infection Studies Webinar
Human Infection Studies Considerations on manufacturing of challenge agents-viruses (SARS-CoV-2/COVID-19) and parasites as examples
March 31, 2021
A Joint Wellcome Trust/HIC-Vac, hVIVO and IABS webinar
Platform Technology Webinar
Platform Technology: Is it possible to reduce vaccine development time?
February 18, 2021
A virtual Meeting
IABS-EU_ZAPI Stakeholders Final Conference
February 4-5, 2021
A virtual Meeting
2020
6th Statistics Workshop
Approaches for Improving Statistical Partnership in CMC Development, Manufacturing, and Regulation of Biologicals
November 2-5, 2020
A Virtual Meeting
SARS-CoV-2 Webinar-An Update
October 16, 2020
A virtual Meeting
SARS-CoV-2 CHIM Webinar
June 23, 2020
A virtual Meeting
SARS-CoV-2 Webinar
May 27, 2020
IABS has been asked to organize several webinars in order to share scientific information on SARS-CoV-2.
As science is evolving day after day, it is important for many people to have an overview of the actual knowledge at a specific moment in time.
The first IABS webinar that took place Wednesday May 27th from 14:00-16:00 CEST gave you an insight to what is known about SARS-CoV-2, the epidemiology worldwide, the disease from an immunology viewpoint and where we are today with the development of vaccines against the virus.
This webinar is the first in a series of webinars to inform our network on what is known about the virus, the disease, and how to cope with it.
3rd Human Challenge Trials in Vaccine Development
February 6-7, 2020
3rd Human Challenge Trials in Vaccine Development
5th Cell Therapy Conference, Tokyo, Japan
February 4-5, 2020
5th IABS Cell Therapy Conference Towards international convergence of basic technical requirements and evaluation of human cell therapy products
Muromachi Mitsui Hall & Conference
Tokyo, Japan – Organized by: International Alliance for Biological Standardization (IABS) With the support from: Osaka University Graduate School of Medicine
IABS 65th Anniversary Conference on Infectious Diseases
February 26-28, 2020
New paths for sustainable solutions to tackle global and emerging infectious threats
IABS celebrated its 65th Anniversary on February 26-28, 2020, in Lyon, France.
2019
Animal Testing for Vaccines, Bangkok, Thailand
December 3-4, 2019
Animal Testing for Vaccines Implementing Replacement, Reduction and Refinement: Challenges and Priorities
2nd Conference on Next Generation Sequencing for Adventitious Virus Detection in Human and Veterinary Biologics
November 13-14, 2019
2nd Conference on Next Generation Sequencing
for Adventitious Virus Detection in
Human and Veterinary Biologics
An IABS-EU Meeting
Quality Requirements for Challenge Agents
October 22, 2019
Quality Requirements for Challenge Agents
An IABS-EU Meeting
Towards Rabies Elimination in Asia-Pacific – From Theory to Practice, Bangkok, Thailand
September 25-26, 2019
Towards Rabies Elimination in Asia-Pacific – From Theory to Practice
Diagnostics in the Veterinary Field
May 15-17, 2019
Workshop on Diagnostics in the Veterinary Field: The Role in Health Surveillance and Disease Identification
A workshop focusing on advantages / benefits and disadvantages and gaps of the current methods and methodologies
2018
Implementing Nonanimal Approaches to Human and Veterinary Vaccine Testing
October 16-17, 2018
Workshop: Implementing Non-animal Approaches to Human and Veterinary Vaccine Testing: Achieving Scientific and Regulatory Success for Rabies and Beyond
National Institutes of Health, Bethesda, Maryland
5th Statistical Approaches for CMC Development and Lifecycle Management of Biotherapeutics and Vaccines
November 26-28, 2018
Venue: US Pharmacopeia
Rockville, Maryland
Narcolepsy and Pandemic Influenza Vaccination
Mars 26-27, 2018
Narcolepsy and Pandemic Influenza Vaccination: What we know and what we need to know before the next Pandemic
Eurostation II, Place Victor Horta
Brussels, Belgium
In partnership with
Federal Agency for Medicines and Health Products (FAMHP)
Vaccine Center of Excellence
4th Cell Therapy Conference
June 5-6, 2018
4th Cell Therapy Conference
Manufacturing and Testing of Pluripotent Stem Cells
Organized by The International Alliance for Biological Standardization – IABS
with support from and in collaboration with the California Institute for Regenerative Medicine – CIRM
Los Angeles, California
2017
Autogenous Vaccines and Their Role in Animal Health Strategy
September 25-26, 2017
Autogenous Vaccines and Their Role
in Animal Health Strategy
Venue: Het Pand, University of Ghent
Co-organized by IABS-EU and University of Ghent / PROVAXS
Advancing Analytics for Biotechnology Products
November 6-8, 2017
Advancing Analytics for Biotechnology Products
An IABS – FDA international meeting
co-sponsored by NIST
Venue: NIST, Gathersburg, Maryland
Green Auditorium
Gathersburg, Maryland
4th Statistical and Data Management Approaches for Biotechnology Drug Development
October 30 – November 1, 2017
4th Statistical and Data Management Approaches for Biotechnology Drug Development
Venue: USP Pharmacopeia, Rockville, Maryland
Next Generation Sequencing for Adventitious Virus Detection in Biologics
October 26-27, 2017
Next Generation Sequencing for
Adventitious Virus Detection in BiologicsVenue: USP Pharmacopeia, Rockville, Maryland
2nd Human Challenge Trials Conference
September 28-30, 2017
2nd Human Challenge Trials Conference
Venue: Hilton Hotel, Rockville, Maryland
2016
Harmonized Safety Monitoring of Immunization Pregnancy
March 29-30, 2016
Harmonized Safety Monitoring of Immunization Pregnancy
International Consensus Conference
National Institutes of Health
Bethesda, Maryland, USA
Emerging Diseases in Animals:
Strategies in Surveillance, Control and Eradication
September 28-30, 2016
Co-organized by:
IABS
Paul-Ehrlich-Institut
Hungarian National Food Chain Safety Office
Budapest, Hungary
3rd Statistical and Data Management Approaches for Biotechnology Drug Development
October 11-12, 2016
3rd Statistical and Data Management Approaches
for Biotechnology Drug Development
Co-organized by IABS and FDA
USP Headquarters, Rockville, Maryland
3rd Conference on Cell Therapy Manufacturing and Testing
November 2-3, 2016
3rd IABS conference on cell therapy
Manufacturing and Testing
This meeting provided an important update on the Regulation and Standardization of Cell Therapies
The Wellcome Collection
London, United Kingdom
2015
International Regulatory Endeavour Towards Sound Development of Human Cell Therapy Products
February 18-19, 2015
Venue: Hitotsubashi Hall
Organized by IABS with the support of Pharmaceuticals and Medical devices Agency (PMDA); Japan Science and Technology Agency (JST); National Institute of Biomedical Innovation (NIBIO); World Health Organization (WHO)
Under the auspices of Forum for Innovative Regenerative Medicine (FIRM); Japan Pharmaceutical Manufacturers Association (JPMA); The Japanese Scoiety for Regenerrative Medicine (JSRM)
Tokyo, Japan
2nd Statistical and Data Management Approaches for Biotechnology Drug Development
September 29-30, 2015
2nd Statistical and Data Management Approaches for Biotechnology Drug Development
Venue: US Pharmacopeia Conference Center, Rockville, Maryland
Organized by: IABS anad FDA
2nd Progress and Challenge in Protein Particles and Immonogenicity of Biotherapeutics
November 12-13, 2015
Venue: US Pharmacopeia Conference Center, Rockville, Maryland
Organized by: IABS and Health Canada
2014 Conferences
Click on the link for all the slides and meeting agenda :
> Human Challenge Trials
> Stats & Data
2020 Replay
Dr. Melanie Saville – SARS-CoV-2 Webinar
Replay 27/05/2020
Dr. Melanie Saville, Head of Vaccine R&D, CEPI Vaccines:
Presentation: Vaccine development:
Where are we?
Dr. Melanie Saville – SARS-CoV-2 Webinar
Replay 16/10/2020
Dr. Melanie Saville, Head of Vaccine R&D, CEPI Vaccines:
Prof. Arnaud Marchant – SARS-CoV-2 Webinar
Replay 27/05/2020
Prof. Arnaud Marchant, Director of the Institute for Medical Immunology, Université Libre de Bruxelles
Presentation: Update on SARS-CoV-2 – The disease looked at by the immunologist
Prof. Arnaud Marchant – SARS-CoV-2 Webinar
Replay 16/10/2020
Prof. Arnaud Marchant, Director of the Institute for Medical Immunology, Université Libre de Bruxelles
Prof. Arnaud Fontanet – SARS-CoV-2 Webinar
Replay 16/10/2020
Prof. Arnaud Fontanet, Director of the Department of Global Health, Head of the Emerging Diseases Epidemiology Unit, Institut Pasteur
Prof. Bruno Lina – SARS-CoV-2 Webinar
Replay 27/05/2020
Prof. Bruno Lina, professor of Virology, University Claude Bernard Lyon and Director of the research laboratory VirPath
Presentation Title: What do we know about SARS-CoV-2
Prof. Bruno Lina – SARS-CoV-2 Webinar
Replay 16/10/2020
Prof. Bruno Lina, professor of Virology, University Claude Bernard Lyon and Director of the research laboratory VirPath
